Literature DB >> 34235640

Huntington's Chorea-a Rare Neurodegenerative Autosomal Dominant Disease: Insight into Molecular Genetics, Prognosis and Diagnosis.

Pratik Talukder1, Annapurna Jana2, Shrirupa Dhar2, Saikat Ghosh2.   

Abstract

Huntington's disease is a neurodegenerative autosomal disease results due to expansion of polymorphic CAG repeats in the huntingtin gene. Phosphorylation of the translation initiation factor 4E-BP results in the alteration of the translation control leading to unwanted protein synthesis and neuronal function. Consequences of mutant huntington (mhtt) gene transcription are not well known. Variability of age of onset is an important factor of Huntington's disease separating adult and juvenile types. The factors which are taken into account are-genetic modifiers, maternal protection i.e excessive paternal transmission, superior ageing genes and environmental threshold. A major focus has been given to the molecular pathogenesis which includes-motor disturbance, cognitive disturbance and neuropsychiatric disturbance. The diagnosis part has also been taken care of. This includes genetic testing and both primary and secondary symptoms. The present review also focuses on the genetics and pathology of Huntington's disease.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Aetiology; CAG repeats; Huntington; Neurodegenerative; Pathogenesis

Year:  2021        PMID: 34235640     DOI: 10.1007/s12010-021-03523-x

Source DB:  PubMed          Journal:  Appl Biochem Biotechnol        ISSN: 0273-2289            Impact factor:   2.926


  55 in total

1.  Evidence for a predisposing background for CAG expansion leading to HTT mutation in a Chinese population.

Authors:  Mingyi Ma; Yuan Yang; Huifang Shang; Dan Su; Hao Zhang; Yongxin Ma; Yunqiang Liu; Dachang Tao; Sizhong Zhang
Journal:  J Neurol Sci       Date:  2010-11-15       Impact factor: 3.181

2.  p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.

Authors:  Byoung-Il Bae; Hong Xu; Shuichi Igarashi; Masahiro Fujimuro; Nishant Agrawal; Yoichi Taya; S Diane Hayward; Timothy H Moran; Craig Montell; Christopher A Ross; Solomon H Snyder; Akira Sawa
Journal:  Neuron       Date:  2005-07-07       Impact factor: 17.173

3.  Analysis of the huntingtin gene reveals a trinucleotide-length polymorphism in the region of the gene that contains two CCG-rich stretches and a correlation between decreased age of onset of Huntington's disease and CAG repeat number.

Authors:  D C Rubinsztein; D E Barton; B C Davison; M A Ferguson-Smith
Journal:  Hum Mol Genet       Date:  1993-10       Impact factor: 6.150

4.  Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function.

Authors:  A Pause; G J Belsham; A C Gingras; O Donzé; T A Lin; J C Lawrence; N Sonenberg
Journal:  Nature       Date:  1994-10-27       Impact factor: 49.962

5.  HYPK, a Huntingtin interacting protein, reduces aggregates and apoptosis induced by N-terminal Huntingtin with 40 glutamines in Neuro2a cells and exhibits chaperone-like activity.

Authors:  Swasti Raychaudhuri; Mithun Sinha; Debashis Mukhopadhyay; Nitai P Bhattacharyya
Journal:  Hum Mol Genet       Date:  2007-10-18       Impact factor: 6.150

6.  Sex-dependent mechanisms for expansions and contractions of the CAG repeat on affected Huntington disease chromosomes.

Authors:  B Kremer; E Almqvist; J Theilmann; N Spence; H Telenius; Y P Goldberg; M R Hayden
Journal:  Am J Hum Genet       Date:  1995-08       Impact factor: 11.025

7.  DNA haplotype analysis of Huntington disease reveals clues to the origins and mechanisms of CAG expansion and reasons for geographic variations of prevalence.

Authors:  F Squitieri; S E Andrew; Y P Goldberg; B Kremer; N Spence; J Zeisler; K Nichol; J Theilmann; J Greenberg; J Goto
Journal:  Hum Mol Genet       Date:  1994-12       Impact factor: 6.150

Review 8.  Huntingtin-protein interactions and the pathogenesis of Huntington's disease.

Authors:  Shi-Hua Li; Xiao-Jiang Li
Journal:  Trends Genet       Date:  2004-03       Impact factor: 11.639

9.  Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease.

Authors:  Jayeeta Ghose; Mithun Sinha; Eashita Das; Nihar R Jana; Nitai P Bhattacharyya
Journal:  PLoS One       Date:  2011-08-26       Impact factor: 3.240

10.  GSK-3 directly regulates phospho-4EBP1 in renal cell carcinoma cell-line: an intrinsic subcellular mechanism for resistance to mTORC1 inhibition.

Authors:  Hiromi Ito; Osamu Ichiyanagi; Sei Naito; Vladimir N Bilim; Yoshihiko Tomita; Tomoyuki Kato; Akira Nagaoka; Norihiko Tsuchiya
Journal:  BMC Cancer       Date:  2016-07-07       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.